Hyesun Oh

Hyesun Oh is an accomplished professional in the field of toxicology and drug development, currently serving as Executive Director at Nimbus Therapeutics since May 2022. Prior experience includes roles as Director, Sr. Research Fellow, and Sr. Principal Scientist at Boehringer Ingelheim from January 2014 to May 2022, as well as Associate Director at Celgene Corporation. Hyesun has demonstrated expertise as a Toxicology Project Leader at HOFFMAN-LA ROCHE INC and previous positions at Boehringer Ingelheim, focusing on drug candidates across various therapeutic areas including oncology, immunology, and cardiometabolic disease. Academic credentials include a PhD from North Carolina State University and postdoctoral research at Harvard Medical School.